首页 > 最新文献

The Journal of Bone & Joint Surgery最新文献

英文 中文
Antioxidant-Loaded Highly Cross-Linked Polyethylene May Reduce Revision Risk in Total Knee Arthroplasty: A U.S.-Based Cohort Study. 抗氧化剂负载的高交联聚乙烯可能降低全膝关节置换术的翻修风险:一项美国队列研究。
Pub Date : 2025-11-26 DOI: 10.2106/jbjs.25.00490
Heather A Prentice,Priscilla H Chan,Richard N Chang,Brian H Fasig,Matthew P Kelly,Adrian D Hinman,Steven M Kurtz,Elizabeth W Paxton
BACKGROUNDAlthough the use of highly cross-linked polyethylene (HXLPE) with antioxidants in total knee arthroplasty (TKA) has increased over time, evidence of any benefit in survivorship over HXLPE without antioxidants is lacking. We sought to compare the TKA revision risk for HXLPE with and without antioxidants.METHODSData from the Kaiser Permanente health-care system's total joint replacement registry were used for a cohort study. Adult patients who underwent primary fixed-bearing TKA with patellar resurfacing for osteoarthritis from 2001 to 2023 were included. The study groups were cases of TKA performed with HXLPE with and without antioxidants. The primary outcome was all-cause revision; revisions for septic reasons, any aseptic reasons, wear, and loosening were secondary outcomes. Multivariable Cox proportional-hazards regression was used to evaluate the revision risk by treatment group with an adjustment for covariates.RESULTSThe final study sample included 92,923 TKA cases: 48,846 performed with HXLPE implants with antioxidants and 44,077 performed with HXLPE implants without antioxidants. The mean patient age was 67.7 years, and the mean patient body mass index was 31.2 kg/m2. Most patients were female (64.3%) and White (64.8%) and had an American Society of Anesthesiologists classification of 1 to 2 (65.2%). The 13-year crude revision incidence was 3.4% for the antioxidant group and 4.2% for the group without antioxidants. After we adjusted for confounders, we observed a lower revision risk for the antioxidant group compared with the group without antioxidants (hazard ratio [HR], 0.86 [95% confidence interval (CI), 0.79 to 0.95]). When we investigated revisions for specific reasons, we observed a lower risk for aseptic revision (HR, 0.86 [95% CI, 0.76 to 0.97]) and for wear (HR, 0.41 [95% CI, 0.21 to 0.81]) in the antioxidant group.CONCLUSIONSWe observed a lower risk of al-cause revision and a lower risk of revision specifically for wear in TKA cases performed with HXLPE with antioxidants added.LEVEL OF EVIDENCETherapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
虽然高交联聚乙烯(HXLPE)与抗氧化剂在全膝关节置换术(TKA)中的使用随着时间的推移而增加,但缺乏证据表明与不含抗氧化剂的HXLPE相比,在生存率方面有任何益处。我们试图比较使用和不使用抗氧化剂的HXLPE的TKA修订风险。方法:来自Kaiser Permanente医疗保健系统的全关节置换登记的数据用于队列研究。本研究纳入了2001年至2023年间因骨关节炎接受原发性固定轴承TKA合并髌骨表面置换的成年患者。研究组是有抗氧化剂和无抗氧化剂的HXLPE进行TKA的病例。主要结局为全因修正;脓毒症原因、任何无菌原因、磨损和松动的翻修是次要结果。采用多变量Cox比例风险回归评估各治疗组的修订风险,并对协变量进行调整。结果最终的研究样本包括92923例TKA病例,其中48846例使用含抗氧化剂的HXLPE种植体,44077例使用不含抗氧化剂的HXLPE种植体。患者平均年龄67.7岁,平均体重指数31.2 kg/m2。大多数患者为女性(64.3%)和白人(64.8%),美国麻醉医师学会分级为1 ~ 2(65.2%)。抗氧化剂组的13年粗修正率为3.4%,无抗氧化剂组为4.2%。在校正混杂因素后,我们观察到抗氧化剂组的修订风险低于不服用抗氧化剂组(风险比[HR], 0.86[95%可信区间(CI), 0.79至0.95])。当我们调查特定原因的翻修时,我们观察到抗氧化组无菌翻修的风险(HR, 0.86 [95% CI, 0.76至0.97])和磨损的风险(HR, 0.41 [95% CI, 0.21至0.81])较低。结论:我们观察到添加抗氧化剂的HXLPE治疗TKA患者的全因翻修风险较低,专门针对磨损的翻修风险较低。证据水平:治疗性三级。有关证据水平的完整描述,请参见作者说明。
{"title":"Antioxidant-Loaded Highly Cross-Linked Polyethylene May Reduce Revision Risk in Total Knee Arthroplasty: A U.S.-Based Cohort Study.","authors":"Heather A Prentice,Priscilla H Chan,Richard N Chang,Brian H Fasig,Matthew P Kelly,Adrian D Hinman,Steven M Kurtz,Elizabeth W Paxton","doi":"10.2106/jbjs.25.00490","DOIUrl":"https://doi.org/10.2106/jbjs.25.00490","url":null,"abstract":"BACKGROUNDAlthough the use of highly cross-linked polyethylene (HXLPE) with antioxidants in total knee arthroplasty (TKA) has increased over time, evidence of any benefit in survivorship over HXLPE without antioxidants is lacking. We sought to compare the TKA revision risk for HXLPE with and without antioxidants.METHODSData from the Kaiser Permanente health-care system's total joint replacement registry were used for a cohort study. Adult patients who underwent primary fixed-bearing TKA with patellar resurfacing for osteoarthritis from 2001 to 2023 were included. The study groups were cases of TKA performed with HXLPE with and without antioxidants. The primary outcome was all-cause revision; revisions for septic reasons, any aseptic reasons, wear, and loosening were secondary outcomes. Multivariable Cox proportional-hazards regression was used to evaluate the revision risk by treatment group with an adjustment for covariates.RESULTSThe final study sample included 92,923 TKA cases: 48,846 performed with HXLPE implants with antioxidants and 44,077 performed with HXLPE implants without antioxidants. The mean patient age was 67.7 years, and the mean patient body mass index was 31.2 kg/m2. Most patients were female (64.3%) and White (64.8%) and had an American Society of Anesthesiologists classification of 1 to 2 (65.2%). The 13-year crude revision incidence was 3.4% for the antioxidant group and 4.2% for the group without antioxidants. After we adjusted for confounders, we observed a lower revision risk for the antioxidant group compared with the group without antioxidants (hazard ratio [HR], 0.86 [95% confidence interval (CI), 0.79 to 0.95]). When we investigated revisions for specific reasons, we observed a lower risk for aseptic revision (HR, 0.86 [95% CI, 0.76 to 0.97]) and for wear (HR, 0.41 [95% CI, 0.21 to 0.81]) in the antioxidant group.CONCLUSIONSWe observed a lower risk of al-cause revision and a lower risk of revision specifically for wear in TKA cases performed with HXLPE with antioxidants added.LEVEL OF EVIDENCETherapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145609926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep Learning Model for Differentiating Between Neoplastic Pathologic Fracture and Nonpathologic Fracture Using Hip Radiographs. 基于髋部x线片区分肿瘤病理性骨折和非病理性骨折的深度学习模型。
Pub Date : 2025-11-26 DOI: 10.2106/jbjs.25.00344
Shinn Kim,Kyoungseob Shin,Han-Soo Kim,Yongsung Kim,June Hyuk Kim,Min Wook Joo,Wanlim Kim,Jay Hoon Park,Yoon Joo Cho,Minsu Kim,Sunghoon Kwon,Ilkyu Han
BACKGROUNDAlthough radiographs are the first-line imaging modality, differentiating between neoplastic pathologic fractures and nonpathologic fractures on radiographs can sometimes be challenging. In this study, we aimed to develop and evaluate a deep learning model capable of distinguishing neoplastic pathologic fractures from nonpathologic fractures on hip radiographs to enhance diagnostic accuracy.METHODSThis retrospective, multicenter study analyzed anteroposterior hip radiographs from patients who visited the emergency department at 4 different institutions. The deep learning model was trained on, and tested using, data from 338 patients at a single institution and externally validated on data from 488 patients across 3 additional institutions.RESULTSThe model achieved an overall accuracy of 0.880, with a sensitivity of 0.882 and a specificity of 0.879, on the internal test set. It was then externally validated using the data of 488 patients (67 with neoplastic pathologic fracture and 421 with nonpathologic fracture) from institutions separate from where the model was developed. The model achieved an overall accuracy of 0.848, sensitivity of 0.910, and specificity of 0.786. Its performance was comparable with that of general orthopaedic surgeons.CONCLUSIONSThe developed deep learning model is a reliable and valid tool for distinguishing neoplastic pathologic fractures from nonpathologic fractures on hip radiographs. It has the potential to assist orthopaedic surgeons in resource-limited settings, where optimizing the interpretation of radiographs is critical for patient care. The model is publicly available at https://pathfxdx.org.LEVEL OF EVIDENCEDiagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.
背景虽然x线片是一线成像方式,但在x线片上区分肿瘤性病理性骨折和非病理性骨折有时是具有挑战性的。在这项研究中,我们旨在开发和评估一种深度学习模型,该模型能够在髋关节x线片上区分肿瘤病理性骨折和非病理性骨折,以提高诊断准确性。方法:本研究是一项回顾性、多中心研究,分析了4家不同医院急诊科患者的髋关节正位x线片。深度学习模型使用来自单个机构338名患者的数据进行训练和测试,并使用来自另外3个机构488名患者的数据进行外部验证。结果该模型在内部测试集上的总体准确率为0.880,灵敏度为0.882,特异性为0.879。然后使用来自不同机构的488例患者(67例为肿瘤性病理性骨折,421例为非病理性骨折)的数据对模型进行外部验证。该模型的总体准确率为0.848,灵敏度为0.910,特异性为0.786。其性能可与普通骨科医生相媲美。结论所建立的深度学习模型是一种可靠有效的工具,可以在髋部x线片上区分肿瘤病理性骨折和非病理性骨折。在资源有限的情况下,它有可能帮助骨科医生,在这种情况下,优化x光片的解释对患者护理至关重要。该模型可在https://pathfxdx.org.LEVEL OF EVIDENCEDiagnostic Level III上公开获得。有关证据水平的完整描述,请参见作者说明。
{"title":"Deep Learning Model for Differentiating Between Neoplastic Pathologic Fracture and Nonpathologic Fracture Using Hip Radiographs.","authors":"Shinn Kim,Kyoungseob Shin,Han-Soo Kim,Yongsung Kim,June Hyuk Kim,Min Wook Joo,Wanlim Kim,Jay Hoon Park,Yoon Joo Cho,Minsu Kim,Sunghoon Kwon,Ilkyu Han","doi":"10.2106/jbjs.25.00344","DOIUrl":"https://doi.org/10.2106/jbjs.25.00344","url":null,"abstract":"BACKGROUNDAlthough radiographs are the first-line imaging modality, differentiating between neoplastic pathologic fractures and nonpathologic fractures on radiographs can sometimes be challenging. In this study, we aimed to develop and evaluate a deep learning model capable of distinguishing neoplastic pathologic fractures from nonpathologic fractures on hip radiographs to enhance diagnostic accuracy.METHODSThis retrospective, multicenter study analyzed anteroposterior hip radiographs from patients who visited the emergency department at 4 different institutions. The deep learning model was trained on, and tested using, data from 338 patients at a single institution and externally validated on data from 488 patients across 3 additional institutions.RESULTSThe model achieved an overall accuracy of 0.880, with a sensitivity of 0.882 and a specificity of 0.879, on the internal test set. It was then externally validated using the data of 488 patients (67 with neoplastic pathologic fracture and 421 with nonpathologic fracture) from institutions separate from where the model was developed. The model achieved an overall accuracy of 0.848, sensitivity of 0.910, and specificity of 0.786. Its performance was comparable with that of general orthopaedic surgeons.CONCLUSIONSThe developed deep learning model is a reliable and valid tool for distinguishing neoplastic pathologic fractures from nonpathologic fractures on hip radiographs. It has the potential to assist orthopaedic surgeons in resource-limited settings, where optimizing the interpretation of radiographs is critical for patient care. The model is publicly available at https://pathfxdx.org.LEVEL OF EVIDENCEDiagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145609928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sources of Patients' Expectations of Total Knee Arthroplasty. 患者对全膝关节置换术期望的来源。
Pub Date : 2025-11-26 DOI: 10.2106/jbjs.25.00529
Carol A Mancuso,Roland Duculan,Allina A Nocon,Cynthia A Kahlenberg,Peter K Sculco,Thomas P Sculco
BACKGROUNDUnderstanding the sources of patients' expectations of total knee arthroplasty (TKA) can foster realistic expectations. Sources of expectations may be influenced by clinical and psychological variables, including general disposition or attitude.METHODSPatients undergoing TKA completed a 19-item survey preoperatively that addressed the amount of improvement expected (i.e., "complete" to "a little") for symptoms and physical and psychological well-being. Patients reported the sources of these expectations, which were grouped into categories. Disposition or attitude was assessed for positive affect (e.g., openness to change) and negative affect (e.g., irritability) with use of the Positive and Negative Affect Schedule (PANAS). Clinical status was assessed using the Knee injury and Osteoarthritis Outcome Score-Joint Replacement (KOOS-JR). Expectations and sources of expectations were compared with KOOS-JR and PANAS scores and demographic and clinical characteristics (e.g., symptom duration) with use of statistical analyses.RESULTSA total of 232 patients (mean age, 65 years; 60% women; 17% Latino ethnicity or non-White race) were enrolled 17 ± 8 days preoperatively. Seventy-two percent expected ≥15 of the survey items; complete improvement was expected for 59% of items. Expecting more items was associated with better preoperative KOOS-JR scores (p < 0.0001), more negative affect (p = 0.003), a shorter duration of symptoms (p = 0.01), and not being a college graduate (p = 0.04). Patients volunteered multiple sources of expectations, including favorable outcomes from a previous orthopaedic surgery (11% of patients), knowledge of favorable (56%) and unfavorable (7%) TKA outcomes in others, their current surgeon (15%), avoidance of further knee deterioration (10%), internet information (16%), and general optimism (18%). Citing more sources was associated with worse KOOS-JR scores (p = 0.02) and less positive affect (p = 0.009). Sources of expectations were associated with patient variables; specifically, knowledge of favorable outcomes was associated with better KOOS-JR scores (p = 0.04), knowledge of unfavorable outcomes was associated with more negative affect (p = 0.04), optimism was associated with more positive affect (p = 0.01), and information from the internet was associated with longer symptom duration (p = 0.04) and less negative affect (p = 0.02).CONCLUSIONSPatients had high expectations of TKA and derived these expectations from diverse sources spanning personal and social network experiences. Patients' expectations and/or sources of expectations were associated with functional status and positive and negative affect.LEVEL OF EVIDENCEPrognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
背景了解患者对全膝关节置换术(TKA)期望的来源可以培养切合实际的期望。期望的来源可能受到临床和心理变量的影响,包括一般的性格或态度。方法接受TKA的患者术前完成了一项19项的调查,以解决症状和身心健康的预期改善程度(即“完全”到“一点”)。患者报告了这些期望的来源,这些期望被分成几类。使用积极和消极影响量表(PANAS)评估积极影响(如对改变的开放程度)和消极影响(如易怒)的性格或态度。使用膝关节损伤和骨关节炎结局评分-关节置换术(KOOS-JR)评估临床状况。使用统计分析将期望和期望来源与KOOS-JR和PANAS评分以及人口学和临床特征(如症状持续时间)进行比较。结果术前17±8天共纳入232例患者(平均年龄65岁,女性占60%,拉丁裔或非白种人占17%)。72%的人预计调查项目≥15个;预期59%的项目完全改善。期望更多的项目与术前更好的KOOS-JR评分(p < 0.0001)、更多的负面情绪(p = 0.003)、更短的症状持续时间(p = 0.01)和非大学毕业生(p = 0.04)相关。患者自愿提供了多种期望来源,包括先前骨科手术的良好结果(11%的患者),对他人TKA结果的有利(56%)和不利(7%)的了解,他们当前的外科医生(15%),避免膝关节进一步恶化(10%),互联网信息(16%)和总体乐观(18%)。引用资料越多,KOOS-JR评分越差(p = 0.02),积极影响越少(p = 0.009)。期望的来源与患者变量相关;其中,对良好结果的了解与更高的KOOS-JR评分相关(p = 0.04),对不良结果的了解与更多的负面情绪相关(p = 0.04),乐观与更多的积极情绪相关(p = 0.01),而来自互联网的信息与更长的症状持续时间(p = 0.04)和更少的负面情绪相关(p = 0.02)。结论患者对TKA有较高的期望,这些期望来源于个人和社会网络经验。患者的期望和/或期望的来源与功能状态和积极和消极影响有关。证据水平:预后II级。有关证据水平的完整描述,请参见作者说明。
{"title":"Sources of Patients' Expectations of Total Knee Arthroplasty.","authors":"Carol A Mancuso,Roland Duculan,Allina A Nocon,Cynthia A Kahlenberg,Peter K Sculco,Thomas P Sculco","doi":"10.2106/jbjs.25.00529","DOIUrl":"https://doi.org/10.2106/jbjs.25.00529","url":null,"abstract":"BACKGROUNDUnderstanding the sources of patients' expectations of total knee arthroplasty (TKA) can foster realistic expectations. Sources of expectations may be influenced by clinical and psychological variables, including general disposition or attitude.METHODSPatients undergoing TKA completed a 19-item survey preoperatively that addressed the amount of improvement expected (i.e., \"complete\" to \"a little\") for symptoms and physical and psychological well-being. Patients reported the sources of these expectations, which were grouped into categories. Disposition or attitude was assessed for positive affect (e.g., openness to change) and negative affect (e.g., irritability) with use of the Positive and Negative Affect Schedule (PANAS). Clinical status was assessed using the Knee injury and Osteoarthritis Outcome Score-Joint Replacement (KOOS-JR). Expectations and sources of expectations were compared with KOOS-JR and PANAS scores and demographic and clinical characteristics (e.g., symptom duration) with use of statistical analyses.RESULTSA total of 232 patients (mean age, 65 years; 60% women; 17% Latino ethnicity or non-White race) were enrolled 17 ± 8 days preoperatively. Seventy-two percent expected ≥15 of the survey items; complete improvement was expected for 59% of items. Expecting more items was associated with better preoperative KOOS-JR scores (p < 0.0001), more negative affect (p = 0.003), a shorter duration of symptoms (p = 0.01), and not being a college graduate (p = 0.04). Patients volunteered multiple sources of expectations, including favorable outcomes from a previous orthopaedic surgery (11% of patients), knowledge of favorable (56%) and unfavorable (7%) TKA outcomes in others, their current surgeon (15%), avoidance of further knee deterioration (10%), internet information (16%), and general optimism (18%). Citing more sources was associated with worse KOOS-JR scores (p = 0.02) and less positive affect (p = 0.009). Sources of expectations were associated with patient variables; specifically, knowledge of favorable outcomes was associated with better KOOS-JR scores (p = 0.04), knowledge of unfavorable outcomes was associated with more negative affect (p = 0.04), optimism was associated with more positive affect (p = 0.01), and information from the internet was associated with longer symptom duration (p = 0.04) and less negative affect (p = 0.02).CONCLUSIONSPatients had high expectations of TKA and derived these expectations from diverse sources spanning personal and social network experiences. Patients' expectations and/or sources of expectations were associated with functional status and positive and negative affect.LEVEL OF EVIDENCEPrognostic Level II. See Instructions for Authors for a complete description of levels of evidence.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"145 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145609927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative Gait Speed as a Predictor of Patient-Reported Outcomes After Total Hip Arthroplasty: Insights from Patient Acceptable Symptom State and K-Means Clustering Analyses. 术前步态速度作为全髋关节置换术后患者报告结果的预测因子:来自患者可接受症状状态和k均值聚类分析的见解。
Pub Date : 2025-11-26 DOI: 10.2106/jbjs.25.00542
Yuki Nakao,Satoshi Hamai,Satoshi Yamate,Toshiki Konishi,Shinya Kawahara,Goro Motomura,Takeshi Utsunomiya,Yasuharu Nakashima
BACKGROUNDTotal hip arthroplasty (THA) is a well-established procedure for hip osteoarthritis (OA); however, its clinical outcomes are variable, and the optimal timing for surgery remains unclear. Identifying the preoperative predictors that influence midterm patient-reported outcome measures (PROMs) could improve patient outcomes.METHODSThis retrospective cohort study included 274 Asian patients who underwent primary THA for OA between 2012 and 2018, who completed preoperative physical assessments, and who responded to a postoperative mail survey. Preoperative variables included symptom duration, pain intensity, hip range of motion, lower-limb muscle strength, and 10-m free gait speed. PROMs were assessed using the Oxford Hip Score (OHS) and the Forgotten Joint Score-12 (FJS-12). Clinically meaningful outcomes were assessed using the Patient Acceptable Symptom State (PASS), defined as a score of ≥42 for the OHS and a score of ≥50 for the FJS-12. Additionally, K-means clustering was applied to categorize patients into an excellent outcome group and a control group on the basis of their PROMs.RESULTSMultivariable regression analysis revealed that preoperative gait speed significantly predicted both the OHS and FJS-12 outcomes (p < 0.01). Furthermore, hip flexion range of motion and hip flexion strength were significantly associated with preoperative gait speed (p < 0.01). A receiver operating characteristic (ROC) curve analysis identified a gait speed cutoff value of 0.7 m/s for achieving the PASS for the OHS (area under the curve [AUC]: 0.69; p < 0.01) and a cutoff value of 1.0 m/s for achieving the PASS for the FJS-12 (AUC: 0.60; p = 0.01). K-means clustering identified preoperative gait speed as the sole significant predictor of classification into the excellent outcome group (odds ratio, 5.85; p < 0.01). The ROC curve analysis revealed a gait speed cutoff value of 1.0 m/s for classification into the excellent group (AUC: 0.64; p < 0.01).CONCLUSIONSPreoperative gait speed, which reflects decreased mobility due to hip joint dysfunction, was a significant predictor of midterm PROMs after THA. Maintaining a preoperative gait speed of 1.0 m/s could serve as a critical threshold for achieving favorable postoperative outcomes, regardless of patient age.LEVEL OF EVIDENCEPrognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
背景:全髋关节置换术(THA)是治疗髋关节骨关节炎(OA)的一种成熟的手术;然而,其临床结果是可变的,手术的最佳时机仍不清楚。确定术前影响中期患者报告结果测量(PROMs)的预测因素可以改善患者的预后。方法:本回顾性队列研究纳入了274例亚洲患者,这些患者在2012年至2018年期间因OA接受了原发性THA,他们完成了术前身体评估,并对术后邮件调查做出了回应。术前变量包括症状持续时间、疼痛强度、髋关节活动范围、下肢肌肉力量和10米自由步速。使用牛津髋关节评分(OHS)和遗忘关节评分-12 (FJS-12)对prom进行评估。使用患者可接受症状状态(PASS)评估临床有意义的结果,定义为OHS评分≥42分,FJS-12评分≥50分。此外,采用K-means聚类,根据患者的PROMs将患者分为优秀结果组和对照组。结果多变量回归分析显示,术前步态速度对OHS和FJS-12预后均有显著预测作用(p < 0.01)。此外,髋屈曲活动范围和髋屈曲强度与术前步态速度显著相关(p < 0.01)。通过受试者工作特征(ROC)曲线分析,确定了OHS的步态速度截止值为0.7 m/s(曲线下面积[AUC]: 0.69; p < 0.01), FJS-12的步态速度截止值为1.0 m/s (AUC: 0.60; p = 0.01)。K-means聚类发现术前步态速度是进入优胜者组的唯一显著预测因子(优势比,5.85;p < 0.01)。ROC曲线分析显示,步态速度截断值为1.0 m/s为优组(AUC: 0.64; p < 0.01)。结论术前步态速度反映髋关节功能障碍导致的活动能力下降,是THA术后中期PROMs的重要预测因子。无论患者年龄如何,术前保持1.0 m/s的步速可以作为获得良好术后结果的关键阈值。证据水平:预后III级。有关证据水平的完整描述,请参见作者说明。
{"title":"Preoperative Gait Speed as a Predictor of Patient-Reported Outcomes After Total Hip Arthroplasty: Insights from Patient Acceptable Symptom State and K-Means Clustering Analyses.","authors":"Yuki Nakao,Satoshi Hamai,Satoshi Yamate,Toshiki Konishi,Shinya Kawahara,Goro Motomura,Takeshi Utsunomiya,Yasuharu Nakashima","doi":"10.2106/jbjs.25.00542","DOIUrl":"https://doi.org/10.2106/jbjs.25.00542","url":null,"abstract":"BACKGROUNDTotal hip arthroplasty (THA) is a well-established procedure for hip osteoarthritis (OA); however, its clinical outcomes are variable, and the optimal timing for surgery remains unclear. Identifying the preoperative predictors that influence midterm patient-reported outcome measures (PROMs) could improve patient outcomes.METHODSThis retrospective cohort study included 274 Asian patients who underwent primary THA for OA between 2012 and 2018, who completed preoperative physical assessments, and who responded to a postoperative mail survey. Preoperative variables included symptom duration, pain intensity, hip range of motion, lower-limb muscle strength, and 10-m free gait speed. PROMs were assessed using the Oxford Hip Score (OHS) and the Forgotten Joint Score-12 (FJS-12). Clinically meaningful outcomes were assessed using the Patient Acceptable Symptom State (PASS), defined as a score of ≥42 for the OHS and a score of ≥50 for the FJS-12. Additionally, K-means clustering was applied to categorize patients into an excellent outcome group and a control group on the basis of their PROMs.RESULTSMultivariable regression analysis revealed that preoperative gait speed significantly predicted both the OHS and FJS-12 outcomes (p < 0.01). Furthermore, hip flexion range of motion and hip flexion strength were significantly associated with preoperative gait speed (p < 0.01). A receiver operating characteristic (ROC) curve analysis identified a gait speed cutoff value of 0.7 m/s for achieving the PASS for the OHS (area under the curve [AUC]: 0.69; p < 0.01) and a cutoff value of 1.0 m/s for achieving the PASS for the FJS-12 (AUC: 0.60; p = 0.01). K-means clustering identified preoperative gait speed as the sole significant predictor of classification into the excellent outcome group (odds ratio, 5.85; p < 0.01). The ROC curve analysis revealed a gait speed cutoff value of 1.0 m/s for classification into the excellent group (AUC: 0.64; p < 0.01).CONCLUSIONSPreoperative gait speed, which reflects decreased mobility due to hip joint dysfunction, was a significant predictor of midterm PROMs after THA. Maintaining a preoperative gait speed of 1.0 m/s could serve as a critical threshold for achieving favorable postoperative outcomes, regardless of patient age.LEVEL OF EVIDENCEPrognostic Level III. See Instructions for Authors for a complete description of levels of evidence.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"204 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145609925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Betamethasone and Triamcinolone Acetonide Have Comparable Efficacy as Single Intra-Articular Injections in Knee Osteoarthritis: A Double-Blinded, Randomized Controlled Trial. 倍他米松和曲安奈德与单次关节内注射治疗膝骨性关节炎疗效相当:一项双盲、随机对照试验
Pub Date : 2025-11-21 DOI: 10.2106/jbjs.25.00100
Kittipong Wattanasirisombat,Krit Boontanapibul,Punnawit Pinitchanon,Piya Pinsornsak
BACKGROUNDIntra-articular (IA) corticosteroid injections are commonly used for pain relief and improved function in patients with knee osteoarthritis (OA). However, the optimal corticosteroid preparation remains controversial. The aim of this study was to compare the efficacy of single-shot long-acting corticosteroid (betamethasone) and intermediate-acting corticosteroid (triamcinolone acetonide) injections in knee OA.METHODSThis single-center, double-blinded, randomized controlled trial included 120 patients with symptomatic knee OA who were randomized to receive either a betamethasone (7-mg) or triamcinolone acetonide (40-mg) IA injection and were followed for 6 months. The primary outcomes were the visual analog scale (VAS) pain scores (0 to 100) at rest and during movement at 6 months. The secondary outcomes were the VAS pain during movement, knee flexion angle, modified Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, University of California Los Angeles (UCLA) activity score, Timed Up-and-Go test (TUG), 2-minute walk test (2MWT), and side effects. The analysis focused on between-group comparisons using multilevel regression models.RESULTSThe study population consisted of 120 Thai individuals. Both the betamethasone and triamcinolone groups demonstrated significant reductions in VAS pain at rest starting from day 1 and lasting for up to 6 months. At 6 months, the between-group mean difference in VAS pain at rest was -1 (95% confidence interval [CI], -11 to 8; p = 0.77), indicating no significant difference. Similarly, at 6 months, no significant between-group differences were observed in VAS pain during movement (-3 [95% CI, -13 to 7]; p = 0.51), flexion angle (6 [95% CI, 1 to 10]; p = 0.20), WOMAC score (-4 [95% CI, -11 to 4]; p = 0.91), UCLA activity score (0 [95% CI, -0.5 to 0.6]; p = 0.46), TUG (-1 second [95% CI, -3 to 1]; p = 0.88), or 2MWT (9 meters [95% CI, -1 to 19]; p = 0.47). Acetaminophen and tramadol use were numerically, but not significantly, lower in the betamethasone group (p > 0.05). No serious adverse events occurred.CONCLUSIONSNo significant differences were observed between IA betamethasone and triamcinolone acetonide with respect to VAS pain, functional scores, or performance-based outcomes at 6 months.LEVEL OF EVIDENCETherapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
背景:关节内(IA)皮质类固醇注射通常用于缓解膝关节骨关节炎(OA)患者的疼痛和改善功能。然而,最佳的皮质类固醇制剂仍然存在争议。本研究的目的是比较单次长效皮质类固醇(倍他米松)和中效皮质类固醇(曲安奈德)注射治疗膝关节OA的疗效。方法本研究为单中心、双盲、随机对照试验,纳入120例有症状性膝关节炎患者,随机接受倍他米松(7 mg)或曲安奈德(40 mg)注射,随访6个月。主要结果是6个月时休息和运动时的视觉模拟评分(VAS)疼痛评分(0 - 100)。次要结果为运动时的VAS疼痛、膝关节屈曲角度、改良的西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分、加州大学洛杉矶分校(UCLA)活动评分、定时起身测试(TUG)、2分钟步行测试(2MWT)和副作用。分析重点是使用多水平回归模型进行组间比较。结果研究人群包括120名泰国人。倍他米松组和曲安奈酮组均显示,从第1天开始,持续长达6个月的休息时VAS疼痛显著减轻。6个月时,两组间VAS静息疼痛平均差异为-1(95%可信区间[CI], -11 ~ 8; p = 0.77),差异无统计学意义。同样,在6个月时,没有观察到显著的差异在血管疼痛运动(3(95%可信区间,-13 - 7);p = 0.51),弯曲角(6 [95% CI, 1到10];p = 0.20), WOMAC评分(4 4][95% CI, -11; p = 0.91),加州大学洛杉矶分校活动评分(0 (95% CI, -0.5 - 0.6); p = 0.46),拖船(1秒[95% CI, 3比1];p = 0.88),或2次参与者(9米(95%可信区间,1到19);p = 0.47)。对乙酰氨基酚和曲马多的使用在倍他米松组数值上较低,但不显著(p < 0.05)。未发生严重不良事件。结论:在6个月的VAS疼痛、功能评分或基于表现的结果方面,IA倍他米松和曲安奈德之间没有显著差异。证据级别:治疗性i级。参见《作者说明》获得证据级别的完整描述。
{"title":"Betamethasone and Triamcinolone Acetonide Have Comparable Efficacy as Single Intra-Articular Injections in Knee Osteoarthritis: A Double-Blinded, Randomized Controlled Trial.","authors":"Kittipong Wattanasirisombat,Krit Boontanapibul,Punnawit Pinitchanon,Piya Pinsornsak","doi":"10.2106/jbjs.25.00100","DOIUrl":"https://doi.org/10.2106/jbjs.25.00100","url":null,"abstract":"BACKGROUNDIntra-articular (IA) corticosteroid injections are commonly used for pain relief and improved function in patients with knee osteoarthritis (OA). However, the optimal corticosteroid preparation remains controversial. The aim of this study was to compare the efficacy of single-shot long-acting corticosteroid (betamethasone) and intermediate-acting corticosteroid (triamcinolone acetonide) injections in knee OA.METHODSThis single-center, double-blinded, randomized controlled trial included 120 patients with symptomatic knee OA who were randomized to receive either a betamethasone (7-mg) or triamcinolone acetonide (40-mg) IA injection and were followed for 6 months. The primary outcomes were the visual analog scale (VAS) pain scores (0 to 100) at rest and during movement at 6 months. The secondary outcomes were the VAS pain during movement, knee flexion angle, modified Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, University of California Los Angeles (UCLA) activity score, Timed Up-and-Go test (TUG), 2-minute walk test (2MWT), and side effects. The analysis focused on between-group comparisons using multilevel regression models.RESULTSThe study population consisted of 120 Thai individuals. Both the betamethasone and triamcinolone groups demonstrated significant reductions in VAS pain at rest starting from day 1 and lasting for up to 6 months. At 6 months, the between-group mean difference in VAS pain at rest was -1 (95% confidence interval [CI], -11 to 8; p = 0.77), indicating no significant difference. Similarly, at 6 months, no significant between-group differences were observed in VAS pain during movement (-3 [95% CI, -13 to 7]; p = 0.51), flexion angle (6 [95% CI, 1 to 10]; p = 0.20), WOMAC score (-4 [95% CI, -11 to 4]; p = 0.91), UCLA activity score (0 [95% CI, -0.5 to 0.6]; p = 0.46), TUG (-1 second [95% CI, -3 to 1]; p = 0.88), or 2MWT (9 meters [95% CI, -1 to 19]; p = 0.47). Acetaminophen and tramadol use were numerically, but not significantly, lower in the betamethasone group (p > 0.05). No serious adverse events occurred.CONCLUSIONSNo significant differences were observed between IA betamethasone and triamcinolone acetonide with respect to VAS pain, functional scores, or performance-based outcomes at 6 months.LEVEL OF EVIDENCETherapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145568152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Broken But Not Invisible: Identifying Human Trafficking in Victims with Orthopaedic Injuries. 破碎但并非无形:识别有骨科损伤的人口贩运受害者。
Pub Date : 2025-11-20 DOI: 10.2106/jbjs.25.00963
Haley Ponce,Lindsey Turner,John Coverdale,Phuong Nguyen,Mollie Gordon
Human trafficking is a public health crisis with profound physical and psychological consequences. Orthopaedic surgeons, who are often the earliest providers to assess traumatic musculoskeletal injuries, have a unique opportunity to identify victims of trafficking. This article highlights 4 cases of patients with orthopaedic injuries sustained in the context of trafficking or through the subsequent psychological effects of such encounters. Despite the high percentage of human trafficking victims who interact with the health-care system, the recognition and identification of such victims remain low. We advocate for increased awareness of the possibility of patients with orthopaedic injuries having been trafficked and the consideration of human trafficking in trauma-informed care training.
人口贩运是一场公共卫生危机,具有严重的身心后果。骨科医生往往是评估创伤性肌肉骨骼损伤的最早提供者,他们具有识别贩运受害者的独特机会。本文重点介绍了4例在贩运背景下或在这种遭遇的后续心理影响下遭受骨科损伤的患者。尽管与保健系统互动的人口贩运受害者比例很高,但对这类受害者的认识和鉴定仍然很低。我们提倡提高对骨科损伤患者被贩运的可能性的认识,并在创伤知情护理培训中考虑人口贩运。
{"title":"Broken But Not Invisible: Identifying Human Trafficking in Victims with Orthopaedic Injuries.","authors":"Haley Ponce,Lindsey Turner,John Coverdale,Phuong Nguyen,Mollie Gordon","doi":"10.2106/jbjs.25.00963","DOIUrl":"https://doi.org/10.2106/jbjs.25.00963","url":null,"abstract":"Human trafficking is a public health crisis with profound physical and psychological consequences. Orthopaedic surgeons, who are often the earliest providers to assess traumatic musculoskeletal injuries, have a unique opportunity to identify victims of trafficking. This article highlights 4 cases of patients with orthopaedic injuries sustained in the context of trafficking or through the subsequent psychological effects of such encounters. Despite the high percentage of human trafficking victims who interact with the health-care system, the recognition and identification of such victims remain low. We advocate for increased awareness of the possibility of patients with orthopaedic injuries having been trafficked and the consideration of human trafficking in trauma-informed care training.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"160 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145559136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synovial Fluid MicroRNA Biomarkers Enable Accurate Diagnosis of Hip and Knee Periprosthetic Joint Infections. 滑液MicroRNA生物标志物能够准确诊断髋关节和膝关节假体周围关节感染。
Pub Date : 2025-11-19 DOI: 10.2106/jbjs.24.01559
Bernhard J H Frank,Teresa L Krammer,Jakob Pfeiffer-Vogl,Thi Thu Huong Nguyen,Andreas B Diendorfer,Matthias Hackl,Jochen G Hofstaetter
BACKGROUNDDiagnosing hip and knee periprosthetic joint infections (PJIs) is challenging, necessitating sensitive and specific biomarkers for accurate diagnosis. Cell-free microRNAs (miRNAs) are emerging as noninvasive biomarkers. We hypothesized that hip and knee PJIs are associated with unique cell-free miRNA profiles in synovial fluid, which can be used for the diagnosis of infection.METHODSSynovial fluid samples from 173 Caucasian patients undergoing septic or aseptic revision total joint replacement (TJR) of the hip or knee, as well as samples from 6 osteoarthritic knees, were analyzed. The samples were divided into a discovery group (40 samples; 50% septic) and a validation cohort (133 samples; 35% septic). Small RNA next-generation sequencing (NGS) was used to screen miRNAs in the discovery samples, with reverse transcription-quantitative polymerase chain reaction (RT-qPCR) used to confirm the NGS findings and to validate results in the independent, larger cohort. Logistic regression and cross-validation were applied to assess the diagnostic power of individual and combined miRNAs.RESULTSNGS identified 132 miRNAs with significant differences (false discovery rate < 0.05) between the septic and aseptic synovial fluid samples. Of these, 18 miRNAs were further analyzed with use of RT-qPCR in the independent cohort, with miR-223-3p and miR-338-5p showing the highest increases in septic synovial fluid (log2 fold change >4) and miR-151a-3p and miR-214-3p showing the most substantial reductions. To investigate the performance of the multivariable models, logistic regression was performed by dividing the cohort into a training set (60%) and a test set (40%), which showed improved performance relative to that of the univariate models (median area under the curve [AUC] for the multivariable models, 0.96). A subgroup analysis by joint type, gender, and synovial fluid sample preparation confirmed robust miRNA biomarker performance for PJI.CONCLUSIONSCell-free miRNA levels in the synovial fluid of patients undergoing septic hip or knee TJR were altered in response to infection, indicating immune cell activity in the joint. These miRNAs offer sensitive and specific pathogen-independent biomarkers with potential clinical applications in the diagnosis of hip and knee PJI.LEVEL OF EVIDENCEDiagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.
诊断髋关节和膝关节假体周围关节感染(PJIs)具有挑战性,需要敏感和特异性的生物标志物来准确诊断。无细胞microRNAs (miRNAs)正逐渐成为一种无创生物标志物。我们假设髋关节和膝关节PJIs与滑液中独特的无细胞miRNA谱相关,可用于诊断感染。方法对173例接受髋关节或膝关节全关节置换术(TJR)的白种人患者及6例骨关节炎患者的滑液样本进行分析。样本被分为发现组(40个样本,50%脓毒性)和验证组(133个样本,35%脓毒性)。小RNA下一代测序(NGS)用于筛选发现样本中的mirna,并使用逆转录-定量聚合酶链反应(RT-qPCR)来证实NGS的发现,并在独立的、更大的队列中验证结果。应用逻辑回归和交叉验证来评估单个和组合mirna的诊断能力。结果在脓毒症和无菌滑膜液样本中,sngs共鉴定出132个mirna,差异有统计学意义(假发现率< 0.05)。其中,在独立队列中使用RT-qPCR进一步分析了18个miRNAs, miR-223-3p和miR-338-5p在脓毒性滑液中显示出最高的增加(log2倍变化bbbb4), miR-151a-3p和miR-214-3p显示出最显著的减少。为了研究多变量模型的性能,通过将队列分为训练集(60%)和测试集(40%)进行逻辑回归,结果表明,与单变量模型相比,多变量模型的性能有所提高(多变量模型的曲线下中位数面积[AUC]为0.96)。根据关节类型、性别和滑液样品制备进行的亚组分析证实了PJI的miRNA生物标志物的良好表现。结论脓毒性髋关节或膝关节TJR患者滑液中无细胞miRNA水平因感染而改变,表明关节免疫细胞活性。这些mirna提供了敏感和特异性的不依赖病原体的生物标志物,在诊断髋关节和膝关节PJI方面具有潜在的临床应用价值。证据等级:诊断性三级。有关证据水平的完整描述,请参见作者说明。
{"title":"Synovial Fluid MicroRNA Biomarkers Enable Accurate Diagnosis of Hip and Knee Periprosthetic Joint Infections.","authors":"Bernhard J H Frank,Teresa L Krammer,Jakob Pfeiffer-Vogl,Thi Thu Huong Nguyen,Andreas B Diendorfer,Matthias Hackl,Jochen G Hofstaetter","doi":"10.2106/jbjs.24.01559","DOIUrl":"https://doi.org/10.2106/jbjs.24.01559","url":null,"abstract":"BACKGROUNDDiagnosing hip and knee periprosthetic joint infections (PJIs) is challenging, necessitating sensitive and specific biomarkers for accurate diagnosis. Cell-free microRNAs (miRNAs) are emerging as noninvasive biomarkers. We hypothesized that hip and knee PJIs are associated with unique cell-free miRNA profiles in synovial fluid, which can be used for the diagnosis of infection.METHODSSynovial fluid samples from 173 Caucasian patients undergoing septic or aseptic revision total joint replacement (TJR) of the hip or knee, as well as samples from 6 osteoarthritic knees, were analyzed. The samples were divided into a discovery group (40 samples; 50% septic) and a validation cohort (133 samples; 35% septic). Small RNA next-generation sequencing (NGS) was used to screen miRNAs in the discovery samples, with reverse transcription-quantitative polymerase chain reaction (RT-qPCR) used to confirm the NGS findings and to validate results in the independent, larger cohort. Logistic regression and cross-validation were applied to assess the diagnostic power of individual and combined miRNAs.RESULTSNGS identified 132 miRNAs with significant differences (false discovery rate < 0.05) between the septic and aseptic synovial fluid samples. Of these, 18 miRNAs were further analyzed with use of RT-qPCR in the independent cohort, with miR-223-3p and miR-338-5p showing the highest increases in septic synovial fluid (log2 fold change >4) and miR-151a-3p and miR-214-3p showing the most substantial reductions. To investigate the performance of the multivariable models, logistic regression was performed by dividing the cohort into a training set (60%) and a test set (40%), which showed improved performance relative to that of the univariate models (median area under the curve [AUC] for the multivariable models, 0.96). A subgroup analysis by joint type, gender, and synovial fluid sample preparation confirmed robust miRNA biomarker performance for PJI.CONCLUSIONSCell-free miRNA levels in the synovial fluid of patients undergoing septic hip or knee TJR were altered in response to infection, indicating immune cell activity in the joint. These miRNAs offer sensitive and specific pathogen-independent biomarkers with potential clinical applications in the diagnosis of hip and knee PJI.LEVEL OF EVIDENCEDiagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"23 1","pages":"2561-2573"},"PeriodicalIF":0.0,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145613313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International Consensus Meeting on Infection: Top 10 Evidence-Backed Recommendations and Insights. 感染国际共识会议:十大循证建议和见解。
Pub Date : 2025-11-19 DOI: 10.2106/jbjs.25.00934
{"title":"International Consensus Meeting on Infection: Top 10 Evidence-Backed Recommendations and Insights.","authors":" ","doi":"10.2106/jbjs.25.00934","DOIUrl":"https://doi.org/10.2106/jbjs.25.00934","url":null,"abstract":"","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"175 1","pages":"2537-2540"},"PeriodicalIF":0.0,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145613317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infection and Nonunion Rates in Open Fractures: Description of 6,042 Fractures from the FLOW and PREP-IT Trials. 开放性骨折的感染和不愈合率:来自FLOW和PREP-IT试验的6042例骨折的描述。
Pub Date : 2025-11-19 DOI: 10.2106/jbjs.24.01055
Roman M Natoli,Lucas S Marchand,Sofia Bzovsky,Jennifer E Hagen,Mark J Gage,Christina A Stennett,Nathan N O'Hara,Kyle J Jeray,Brad Petrisor,Sheila Sprague,Gerard P Slobogean, , ,
BACKGROUNDInfection and nonunion are common sequelae of open fractures. Studies have shown infection and nonunion rates ranging from 2% to 52% and 12% to 17%, respectively. The present article describes the rates of surgical site infection (SSI) and delayed union/nonunion following open fractures in a large contemporary series of patients from prospective clinical trials with adjudicated outcomes.METHODSA descriptive analysis was performed with use of patient data from the FLOW, Aqueous-PREP, and PREPARE-Open studies. These studies, published within the past 10 years, included multiple international trauma centers and shared definitions for SSI and delayed union/nonunion. SSI and delayed union/nonunion rates were stratified by the OTA/AO fracture and Gustilo-Anderson open fracture classification systems. Kaplan-Meier estimators were utilized to obtain point estimates, and the log-log transformation approach was utilized to calculate 95% confidence intervals (CIs) for outcome rates.RESULTSA total of 6,042 open fractures were included. The cumulative SSI rates at 12 months for Gustilo-Anderson Types 1, 2, 3A, 3B, and 3C were 5.1%, 9.7%, 13.8%, 28.9%, and 26.2%, respectively. The cumulative rates of delayed union/nonunion at 12 months for Gustilo-Anderson Types 1, 2, 3A, 3B, and 3C were 3.0%, 5.2%, 8.0%, 14.0%, and 17.0%, respectively. Utilizing the OTA/AO fracture classification to increase the point estimate granularity, the estimated 12-month SSI and delayed union/nonunion rates in 156 Gustilo-Anderson type 3B open tibial shaft fractures (OTA/AO 42) were 34.7% (95% CI, 26.7% to 41.9%) and 18.4% (95% CI, 12.0% to 24.4%), respectively. A companion website with SSI and delayed union/nonunion rates was developed to supplement this article.CONCLUSIONSOpen fractures are a substantial problem with complications that include infection and nonunion. The present data are useful for prognosis, research study design, and informing public awareness and policy. These results show that, despite current treatment approaches, the rates of SSI and delayed union/nonunion following treatment of open fractures remain high at 1 year and are not substantially improved from historical rates spanning several decades. Although open fracture sequelae remain a burden for patients, orthopaedic surgeons, and health-care systems, there may be opportunities for improvement in outcomes.LEVEL OF EVIDENCEPrognostic Level I. See Instructions for Authors for a complete description of levels of evidence.
背景:感染和骨不愈合是开放性骨折常见的后遗症。研究表明,感染和骨不连率分别为2%至52%和12%至17%。本文描述了开放性骨折后手术部位感染(SSI)和延迟愈合/不愈合的发生率,这些发生率来自于前瞻性临床试验的大量当代患者,结果已确定。方法使用FLOW、Aqueous-PREP和PREPARE-Open研究的患者数据进行描述性分析。这些研究发表于过去10年,包括多个国际创伤中心,并共享SSI和延迟愈合/不愈合的定义。采用OTA/AO骨折和gustillo - anderson开放性骨折分类系统对SSI和延迟愈合/不愈合率进行分层。使用Kaplan-Meier估计器获得点估计,并使用对数-对数变换方法计算转归率的95%置信区间(ci)。结果共纳入6042例开放性骨折。Gustilo-Anderson型1、2、3A、3B和3C的12个月累积SSI率分别为5.1%、9.7%、13.8%、28.9%和26.2%。Gustilo-Anderson 1、2、3A、3B和3C型患者12个月延迟愈合/不愈合累积率分别为3.0%、5.2%、8.0%、14.0%和17.0%。利用OTA/AO骨折分类增加点估计粒度,156例Gustilo-Anderson型3B开放性胫骨骨干骨折(OTA/AO 42)的12个月SSI和延迟愈合/不愈合率分别为34.7% (95% CI, 26.7%至41.9%)和18.4% (95% CI, 12.0%至24.4%)。为了补充这篇文章,我们开发了一个包含SSI和延迟愈合/不愈合率的配套网站。结论开放性骨折是一个严重的并发症,包括感染和不愈合。目前的数据对预测、研究设计、告知公众意识和政策是有用的。这些结果表明,尽管采用了目前的治疗方法,开放性骨折治疗后1年内SSI和延迟愈合/不愈合的发生率仍然很高,并且与几十年来的历史发生率相比没有显著改善。尽管开放性骨折后遗症仍然是患者、骨科医生和卫生保健系统的负担,但可能有改善结果的机会。证据等级:预后i级。参见《作者说明》获得证据等级的完整描述。
{"title":"Infection and Nonunion Rates in Open Fractures: Description of 6,042 Fractures from the FLOW and PREP-IT Trials.","authors":"Roman M Natoli,Lucas S Marchand,Sofia Bzovsky,Jennifer E Hagen,Mark J Gage,Christina A Stennett,Nathan N O'Hara,Kyle J Jeray,Brad Petrisor,Sheila Sprague,Gerard P Slobogean, , , ","doi":"10.2106/jbjs.24.01055","DOIUrl":"https://doi.org/10.2106/jbjs.24.01055","url":null,"abstract":"BACKGROUNDInfection and nonunion are common sequelae of open fractures. Studies have shown infection and nonunion rates ranging from 2% to 52% and 12% to 17%, respectively. The present article describes the rates of surgical site infection (SSI) and delayed union/nonunion following open fractures in a large contemporary series of patients from prospective clinical trials with adjudicated outcomes.METHODSA descriptive analysis was performed with use of patient data from the FLOW, Aqueous-PREP, and PREPARE-Open studies. These studies, published within the past 10 years, included multiple international trauma centers and shared definitions for SSI and delayed union/nonunion. SSI and delayed union/nonunion rates were stratified by the OTA/AO fracture and Gustilo-Anderson open fracture classification systems. Kaplan-Meier estimators were utilized to obtain point estimates, and the log-log transformation approach was utilized to calculate 95% confidence intervals (CIs) for outcome rates.RESULTSA total of 6,042 open fractures were included. The cumulative SSI rates at 12 months for Gustilo-Anderson Types 1, 2, 3A, 3B, and 3C were 5.1%, 9.7%, 13.8%, 28.9%, and 26.2%, respectively. The cumulative rates of delayed union/nonunion at 12 months for Gustilo-Anderson Types 1, 2, 3A, 3B, and 3C were 3.0%, 5.2%, 8.0%, 14.0%, and 17.0%, respectively. Utilizing the OTA/AO fracture classification to increase the point estimate granularity, the estimated 12-month SSI and delayed union/nonunion rates in 156 Gustilo-Anderson type 3B open tibial shaft fractures (OTA/AO 42) were 34.7% (95% CI, 26.7% to 41.9%) and 18.4% (95% CI, 12.0% to 24.4%), respectively. A companion website with SSI and delayed union/nonunion rates was developed to supplement this article.CONCLUSIONSOpen fractures are a substantial problem with complications that include infection and nonunion. The present data are useful for prognosis, research study design, and informing public awareness and policy. These results show that, despite current treatment approaches, the rates of SSI and delayed union/nonunion following treatment of open fractures remain high at 1 year and are not substantially improved from historical rates spanning several decades. Although open fracture sequelae remain a burden for patients, orthopaedic surgeons, and health-care systems, there may be opportunities for improvement in outcomes.LEVEL OF EVIDENCEPrognostic Level I. See Instructions for Authors for a complete description of levels of evidence.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"130 1","pages":"2541-2553"},"PeriodicalIF":0.0,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145613367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Utility of a Rapid Myeloperoxidase Test in Synovial Fluid for Chronic Periprosthetic Joint Infection. 滑液中髓过氧化物酶快速检测对慢性假体周围关节感染的诊断价值
Pub Date : 2025-11-19 DOI: 10.2106/jbjs.24.01514
Shinsuke Ikeda,Katsufumi Uchiyama,Yojiro Minegishi,Masaki Nakamura,Shotaro Maehana,Ryotaro Eda,Makoto Kubo,Gen Inoue,Masashi Takaso
BACKGROUNDNumerous biomarkers have been identified for the diagnosis of periprosthetic joint infection (PJI), but no single biomarker has been proven to have definitive accuracy. Alpha-defensin is an excellent biomarker that is included as a minor criterion in the 2nd International Consensus Meeting (ICM) PJI diagnostic criteria; however, its high cost limits its accessibility at many general medical facilities. Consequently, alternative biomarkers for PJI diagnosis are under investigation. Myeloperoxidase (MPO), an enzyme with microbicidal properties through the catalysis of hypochlorous acid production, has emerged as a promising alternative. MPO has previously been reported as an effective biomarker for PJI. In the present study, we conducted a rapid MPO test as a point-of-care test (POCT) and evaluated its diagnostic utility.METHODSPatients with a suspected infection after total joint arthroplasty were categorized into the PJI or aseptic failure groups according to the 2nd ICM PJI diagnostic criteria. MPO and alpha-defensin levels in synovial fluid that was collected during surgery were quantified using an enzyme-linked immunosorbent assay (ELISA), and their diagnostic accuracy was compared. Additionally, an MPO POCT was conducted, and its diagnostic accuracy was assessed.RESULTSThe investigation included 23 patients with PJI and 23 with aseptic failure. All were Japanese. MPO and alpha-defensin ELISAs exhibited a strong correlation, and, at the optimal cutoff, both tests demonstrated a sensitivity of 0.957 and a specificity of 0.957. The MPO POCT produced results in just 10 minutes and achieved a sensitivity of 1.00 and a specificity of 0.913.CONCLUSIONSThe MPO ELISA demonstrated high diagnostic accuracy for PJI, equivalent to that of the alpha-defensin test. Furthermore, the MPO POCT showed similarly high diagnostic accuracy. The MPO POCT is a promising and rapid tool for diagnosing PJI and could serve as an alternative to the alpha-defensin test.LEVEL OF EVIDENCEDiagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.
背景:许多生物标志物已被确定用于诊断假体周围关节感染(PJI),但没有一种生物标志物被证明具有明确的准确性。α -防御素是一种优秀的生物标志物,被列入第二届国际共识会议(ICM) PJI诊断标准的次要标准;然而,它的高成本限制了在许多普通医疗机构的可及性。因此,PJI诊断的替代生物标志物正在研究中。髓过氧化物酶(MPO)是一种通过催化次氯酸产生而具有杀微生物特性的酶,已成为一种很有前途的替代品。MPO曾被报道为PJI的有效生物标志物。在本研究中,我们进行了快速MPO测试作为护理点测试(POCT),并评估其诊断效用。方法将全关节置换术后疑似感染患者按照ICM第二版PJI诊断标准分为PJI组和无菌失败组。采用酶联免疫吸附试验(ELISA)对术中收集的滑液中的MPO和α -防御素水平进行定量分析,并比较其诊断准确性。此外,进行MPO POCT,并评估其诊断准确性。结果共纳入PJI患者23例,无菌性失败患者23例。所有人都是日本人。MPO和α -防御素elisa表现出很强的相关性,在最佳截止点,两种检测的敏感性为0.957,特异性为0.957。MPO POCT仅在10分钟内产生结果,灵敏度为1.00,特异性为0.913。结论MPO酶联免疫吸附试验对PJI具有较高的诊断准确性,与α -防御素试验相当。此外,MPO POCT显示出同样高的诊断准确性。MPO POCT是一种有前途的快速诊断PJI的工具,可以作为α -防御素测试的替代方法。证据水平诊断二级。有关证据水平的完整描述,请参见作者说明。
{"title":"Diagnostic Utility of a Rapid Myeloperoxidase Test in Synovial Fluid for Chronic Periprosthetic Joint Infection.","authors":"Shinsuke Ikeda,Katsufumi Uchiyama,Yojiro Minegishi,Masaki Nakamura,Shotaro Maehana,Ryotaro Eda,Makoto Kubo,Gen Inoue,Masashi Takaso","doi":"10.2106/jbjs.24.01514","DOIUrl":"https://doi.org/10.2106/jbjs.24.01514","url":null,"abstract":"BACKGROUNDNumerous biomarkers have been identified for the diagnosis of periprosthetic joint infection (PJI), but no single biomarker has been proven to have definitive accuracy. Alpha-defensin is an excellent biomarker that is included as a minor criterion in the 2nd International Consensus Meeting (ICM) PJI diagnostic criteria; however, its high cost limits its accessibility at many general medical facilities. Consequently, alternative biomarkers for PJI diagnosis are under investigation. Myeloperoxidase (MPO), an enzyme with microbicidal properties through the catalysis of hypochlorous acid production, has emerged as a promising alternative. MPO has previously been reported as an effective biomarker for PJI. In the present study, we conducted a rapid MPO test as a point-of-care test (POCT) and evaluated its diagnostic utility.METHODSPatients with a suspected infection after total joint arthroplasty were categorized into the PJI or aseptic failure groups according to the 2nd ICM PJI diagnostic criteria. MPO and alpha-defensin levels in synovial fluid that was collected during surgery were quantified using an enzyme-linked immunosorbent assay (ELISA), and their diagnostic accuracy was compared. Additionally, an MPO POCT was conducted, and its diagnostic accuracy was assessed.RESULTSThe investigation included 23 patients with PJI and 23 with aseptic failure. All were Japanese. MPO and alpha-defensin ELISAs exhibited a strong correlation, and, at the optimal cutoff, both tests demonstrated a sensitivity of 0.957 and a specificity of 0.957. The MPO POCT produced results in just 10 minutes and achieved a sensitivity of 1.00 and a specificity of 0.913.CONCLUSIONSThe MPO ELISA demonstrated high diagnostic accuracy for PJI, equivalent to that of the alpha-defensin test. Furthermore, the MPO POCT showed similarly high diagnostic accuracy. The MPO POCT is a promising and rapid tool for diagnosing PJI and could serve as an alternative to the alpha-defensin test.LEVEL OF EVIDENCEDiagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.","PeriodicalId":22625,"journal":{"name":"The Journal of Bone & Joint Surgery","volume":"39 1","pages":"2574-2581"},"PeriodicalIF":0.0,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145613366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Journal of Bone & Joint Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1